CIK 0001649094
- Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464233385
- Phone
- +1 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- 4 Open-market sale VP, Research sold 10,000 shares at $25.50 ($255,000)
- 4 Open-market sale SVP Process Dev, Manufacturing sold 6,000 shares at $25.00 ($150,000)
- 4 Grant or award Chief Operating Officer acquired 25,000 shares (grant or award)
- 4 Grant or award VP, Research acquired 6,000 shares (grant or award)
- 4 Grant or award SVP Cml Mfg & Supply Chain acquired 17,500 shares (grant or award)
- 4 Grant or award SVP Process Dev, Manufacturing acquired 10,000 shares (grant or award)
- 4 Grant or award President and CFO acquired 37,500 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 71,875 shares (grant or award)
- 4 Open-market sale President and CFO sold 6,200 shares at $24.00 ($148,800)
- 4 Open-market sale Chief Operating Officer sold 10,000 shares at $22.00 ($220,000)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 16 of 22 · 421 filings